Intelligent Bio Solutions Inc. · NASDAQ:INBS
Intelligent Bio Solutions — Investor Presentation (December 2025)
23 slides from Intelligent Bio Solutions's investor presentation, Dec 2, 2025
Slide 1: Intelligent Bio Solutions: Pioneering Pain-free Solutions
INTELLIGENT BIO SOLUTIONS Pioneering | 2? Pain-free Solutions SS Transforming drug testing with non-invasive, Ny cost-effective, reliable solutions. LQ? \ NASDAQ: INBS | December 2025
Slide 2: Forward Looking Statements
Forward Looking Statements Certain statements in this presentation may constitute “forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended [the "Securities Act’), Section 21E of the Securities Exchange Act of 1954 (the “Exchange Act}, the Private Securities Li
Slide 3: We are a medical technology company
We are a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Our mission is to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Slide 4: NASDAQ: INBS
NASDAQ: INBS
Slide 5: The journey of a drug through the body
The journey of a drug through the body: Absorption: how the drug moves from the site of administration to the site of action. Distribution: the journey of the drug through the bloodstream to various tissues of the body. Metabolism: the process that breaks down the drug. Excretion: the removal of the
Slide 6: Steps to Simpler Drug Testing
3 Steps to Simpler Drug Testing 1 Donor places the tip of each finger on the fingerprint collection area for 5seconds. Test administrator inserts the cartridge into the digital reader. In less than 10 minutes the reader provides results.
Slide 7: Drug Testing benefits
roepine = OQ Drug Testing Reduce Risk Save Costs Increase Efficiency Aim to identify current testit Rapidly collect samples impairment rather than in-house and eliminate and employ batch testing past use with a detection the need for to analyze drug screening window of 16-24 hours. staff or faciliti
Slide 8: Intelligent Fingerprinting vs Urine & Saliva Drug Testing
Intelligent Fingerprinting vs Urine & Saliva Drug Testing =] co Fingerprint Up to 4 days Detection Window 16 - 24 hours Up to 2 days Average Test Time 5 Up to 20 minutes 20 minutes - 4 hours or more Average Cost * ~ USD$5,500 ~ USD$7,600 ~ USD$7,750 Accuracy Up to 99% Up to 98% Up to 99% * Bosed on
Slide 9: SmarTest Sweat Drug Testing Patch
NASDAQ: INBS SmarTest Sweat Drug Testing Patch Non-invasive, Wearable Sweat Patch For Continuous Drug Monitoring The SmarTest Patch is a discreet, wearable device that enables continuous drug detection over a7 to 10-day period. Worn on the upper arm, it collects sweat in real time to monitor for a b
Slide 10: Market Opportunity
Slide 11: Addressing a $400 Billion Substance Abuse Problem
Addressing a $400 Billion Substance Abuse Problem! The global market for Drug Screening was valued at US$12.6 Billion in 2024 and is projected to reach US$318 Billion by 2030, growing at a CAGR of 16.7%. The Drug Screening Products segment is projected to reach US$16.7 billion by 2030 (CAGR 14%?) Ma
Slide 12: Growing Drug Consumption
Growing Drug Consumption Approximately 316 million people used a drug in 2023, a 28% increase over the last 10 years. 31 million cannabis users, opioid users, amphetamine users, cocaine users, representing representing 4.6% of the representing 1.2% of the representing 0.58% of the 0.47% of the globa
Slide 13: More Than 70% of Those Abusing Alcohol or Illicit Drugs in the US Are Employed
More Than 70% of Those Abusing Alcohol or Illicit Drugs in the US Are Employed! Illicit drugs are increasingly contributing to accidents in the workplace. Drug test positivity post-accident has climbed over the last five years? INBS is preparing for FDA clearance to expand beyond Forensic Use Only s
Slide 14: Drug and Alcohol Testing per Industry 2021
Drug and Alcohol Testing per Industry 2021 Percentage Of New And Current Employees! Transportation and warehousing Retail trade Wholesale trade Manufacturing Construction Utilities Natural resources and mining Total U.S, private sector 0% 10% 20% += 30% = 40% += 50% NASDAQ: INBS 60%
Slide 15: ) E UO
0 ) E 3 5 UO
Slide 16: Customer Accounts
Customer Accounts 480+ Active Accounts Across 27 Countries ; 99 NASDAQ: INBS 9 We. W 9 9 9 a 1 “dgp, — SInegarty Ey TotalRecycing ~All fastemZ PREMIERS RobinsonBrothers @gwer explore @ A & abellio™ = a wcsauss — (E) WEE “Parerways = Bdovohey = CROWN seais swuco err estas seid zi howe = Zweber frre P
Slide 17: Target Sectors
Target Sectors Beyond Safety-Critical Workplace Settings Government + Public safety and compliance initiatives + Border security and customs screening + Workplace safety programs across state agencies + Defense and national security applications + Emergency and frontline workforce testing Law Enforc
Slide 18: A&F Sprinklers Testimonial
A&F Sprinklers Testimonial “The process is efficient, seamless, non-invasive, and portable, which is great for us because we have sites all over the country. It’s painless. There are two key results: One, our team is more appreciative of why we do it and it’s talked about more. Two, our non-negative
Slide 19: Precision Stevedores Testimonial
Slide 20: Summary
Summary we Increased revenue and growth, utilizing the Razor/Razor- blade model. NASDAQ: INBS Large growing customer base with 1700+ installed readers and 480+ active customers. ° Multiple milestones completed as we progress toward planned U.S. market entry. a) Rapid, non-invasive, cost-effective so
Slide 21: Record quarterly revenue of $1.11 million
NASDAQ: INBS Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year- over-year, driven by consumable cartridge sales and customer base expansion. Gross profit margins increased 690 basis points year-over-year to 46.6%, reflecting improved operational efficiency and g
Slide 22: Share structure as of November 19, 2025
of November 19, 2025) Common Stock Issued 9,502,969 Warrants Prefunded/Pre-paid 602,470 / Total Common Equivalent Shares 10,105,439 Warrants Cashless 492 Warrants (Exercise Price Between $190- $0 7316491 Warrants Common Stock Equivalent - WAEP of $388.91 1e7291 *No ratchets or resets. NASDAQ: INBS
Slide 23: Thank You
Thank You www.ibs.ine | info@ibs.inc
Intelligent Bio Solutions — Investor Presentation (December 2025) on 6ix